ARTICLE SUMMARY:
Verisante’s optical system diagnoses early-stage cancers based on next-generation, rapid Ramon spectroscopy.
Skin cancer is one of the most common cancers. Caught early, it is highly curable, but a number of hurdles prevent widespread early diagnosis. Current methods rely on initial visual inspection, which errs towards false-positive diagnosis, followed by tissue biopsy, which is a subjective, invasive, and time-consuming procedure.
